ArticleBritish journal of haematology2011

Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma.

Sally A Hunsucker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.